Adiponectin vs Insulin Degludec
Head-to-head comparison of Adiponectin (Adiponectin (Acrp30, AdipoQ)) and Insulin Degludec (Insulin degludec (desB30, acylated ultra-long-acting insulin analog)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Adiponectin | Insulin Degludec |
|---|---|---|
| Category | Diabetes & Metabolic | Diabetes & Metabolic |
| Full Name | Adiponectin (Acrp30, AdipoQ) | Insulin degludec (desB30, acylated ultra-long-acting insulin analog) |
| Molecular Weight | ~26.4 kDa (monomer) | 6103.9 Da |
| Half-Life | ~2-4 h | More than 25 hours |
| Amino Acids | 244 | 50 |
| Typical Dose | No approved human dose; research use only | 0.1-0.2 U/kg once daily |
| Route | IV|SC | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 86 | 7000 |
| Research Status | Pre-clinical | Approved |
Adiponectin Benefits
- ✓insulin sensitivity
- ✓fatty-acid oxidation
- ✓AMPK activation
Insulin Degludec Benefits
- ✓Ultra-long basal coverage
- ✓Lower day-to-day variability
- ✓Reduced nocturnal hypoglycemia
- ✓Flexible dosing time
Adiponectin Dosing
not established|not established
Insulin Degludec Dosing
Inject SC once daily|Titrate to fasting glucose and HbA1c response|May be administered with flexible timing in adults
Adiponectin Side Effects
- ⚠unknown
- ⚠immunogenicity risk
Insulin Degludec Side Effects
- ⚠Hypoglycemia
- ⚠Injection-site reactions
- ⚠Weight gain
Research Overview
Adiponectin
Preclinical and translational studies link adiponectin signaling with better glycemic control, lower inflammation, and improved lipid handling. Recombinant adiponectin and receptor-targeting approaches remain research tools rather than approved diabetes therapies.
Insulin Degludec
Studies highlight prolonged action and lower glycemic variability compared with many other basal insulins. It is frequently used in research on ultra-long basal coverage and hypoglycemia reduction.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.